Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination
NCT ID: NCT04259567
Last Updated: 2020-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2020-06-08
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy
NCT01926301
Cerebrovascular Autoregulation During Sepsis
NCT01029080
Adjuvant Therapy With CytoSorb in Refractory Septic Shock
NCT04013269
Cytokine Adsorption in Severe, Refractory Septic Shock
NCT04910893
A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
NCT04963920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Filter
Patients with CytoSorb absorber
Cytokine absorption
Use of CytoSorb absorber
Control
Patients without CytoSorb absorber
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cytokine absorption
Use of CytoSorb absorber
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acute renal failure with need for renal replacement therapy
Exclusion Criteria
* nursing
* impossibility to do transcranial Doppler ultrasound
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrick Schramm
Deputy intensive care unit, Principal investigator, medical doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center of the Johannes Gutenberg-Univerity
Mainz, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V1.0_2019_06_28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.